Authum investment acquires 3% stake in Serovia Pharma

Authum Investment & Infrastructure Limited has signed an investment agreement dated September 15, 2025, to acquire a 3% stake in Serovia Pharma Private Limited. This acquisition involves subscribing to 18,95,053 Series B compulsorily convertible preference shares, representing three percent of Serovia Pharma's expanded share capital on a fully diluted basis.

The total cost of acquisition is INR 3,000,001,553, for shares priced at INR 10 face value plus a premium of INR 1573.07 per share, totaling INR 1583.07 per share. Authum will pay 50% of the subscription amount, INR 150,00,00,776.50, on application, with the balance payable on call.

Serovia Pharma, incorporated on July 19, 2025, will focus on developing, manufacturing, and distributing pharmaceutical products globally, with intentions to expand its presence to Cyprus and the US. This investment aligns with Authum's long-term strategy to diversify its portfolio into stable and high-growth sectors.